Reversal of drug resistance in ovarian cancer: Where do we go from here?

被引：40

作者：

Kaye, Stan B. ^{[1
,2
]}

机构：

[1] Royal Marsden Hosp, Surrey, England

[2] Inst Canc Res, Surrey, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 16期

关键词：

D O I：

10.1200/JCO.2008.16.2123

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2616 / 2618

页数：3

共 29 条

[1] Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].

Agarwal, R ;

Kaye, SB .

NATURE REVIEWS CANCER, 2003, 3 (07) :502-516

[2] Expression profiling and individualisation of treatment for ovarian cancer [J].

Agarwal, Roshan ;

Kaye, Stan B. .

CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (04) :345-349

[3] Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors [J].

Appleton, Kim ;

Mackay, Helen J. ;

Judson, Ian ;

Plumb, Jane A. ;

McCormick, Carol ;

Strathdee, Gordon ;

Lee, Chooi ;

Barrett, Sophie ;

Reade, Sarah ;

Jadayel, Dalal ;

Tang, Adrian ;

Bellenger, Katharine ;

Mackay, Lynsay ;

Setanoians, Albert ;

Schaetzlein, Andreas ;

Twelves, Chris ;

Kaye, Stanley B. ;

Brown, Robert .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) :4603-4609

[4] Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer [J].

Bapat, SA ;

Mali, AM ;

Koppikar, CB ;

Kurrey, NK .

CANCER RESEARCH, 2005, 65 (08) :3025-3029

[5] DETECTION OF P-GLYCOPROTEIN IN OVARIAN-CANCER - A MOLECULAR MARKER ASSOCIATED WITH MULTIDRUG RESISTANCE [J].

BELL, DR ;

GERLACH, JH ;

KARTNER, N ;

BUICK, RN ;

LING, V .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) :311-315

[6] High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer [J].

Bernardini, M ;

Lee, CH ;

Beheshti, B ;

Prasad, M ;

Albert, M ;

Marrano, P ;

Begley, H ;

Shaw, P ;

Covens, A ;

Murphy, J ;

Rosen, B ;

Minkin, S ;

Squire, JA ;

Macgregor, PF .

NEOPLASIA, 2005, 7 (06) :603-613

[7]

Chen T, 2005, MOL CANCER THER, V4, P217

[8] Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis [J].

Donnenberg, VS ;

Donnenberg, AD .

JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (08) :872-877

[9] RETRACTED: An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Retracted article. See vol. 30, pg. 678, 2012) [J].

Dressman, Holly K. ;

Berchuck, Andrew ;

Chan, Gina ;

Zhai, Jun ;

Bild, Andrea ;

Sayer, Robyn ;

Cragun, Janiel ;

Clarke, Jennifer ;

Whitaker, Regina S. ;

Li, LiHua ;

Gray, Jonathan ;

Marks, Jeffrey ;

Ginsburg, Geoffrey S. ;

Potti, Anil ;

West, Mike ;

Nevins, Joseph R. ;

Lancaster, Johnathan M. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :517-525

[10] Resistance to therapy caused by intragenic deletion in BRCA2 [J].

Edwards, Stacey L. ;

Brough, Rachel ;

Lord, Christopher J. ;

Natrajan, Rachael ;

Vatcheva, Radost ;

Levine, Douglas A. ;

Boyd, Jeff ;

Reis-Filho, Jorge S. ;

Ashworth, Alan .

NATURE, 2008, 451 (7182) :1111-U8

← 1 2 3 →